Details for Patent: 5,683,677
Summary for Patent: 5,683,677
| Title: | Medicinal aerosol formulations |
| Abstract: | A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane. |
| Inventor(s): | Tarlochan S. Purewal, David J. Greenleaf |
| Assignee: | 3M Innovative Properties Co |
| Application Number: | US08/455,012 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Delivery; |
Drugs Protected by US Patent 5,683,677
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,683,677
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 88284773 | Dec 06, 1988 |
International Family Members for US Patent 5,683,677
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 4595689 | ⤷ Start Trial | |||
| Australia | 631155 | ⤷ Start Trial | |||
| Canada | 2004598 | ⤷ Start Trial | |||
| Canada | 2303601 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
